Searched for
CYTOKINES RELEASE STORM
Simple laboratory tests are playing an important role in risk stratification of Covid-19Patients with severe Covid-19, are prone to a cytokine storm, that can be fatal. A cytokine storm in an uncontrollable secretion of pro-inf...17 Nov, 2020, 03.37 PM IST- Arthritis drug may improve COVID-19 survival among elderly patients, says studyIn the research, published in the journal Science Advances, 83 patients with a median age of 81 and all suffering from moderate to severe C...16 Nov, 2020, 04.27 PM IST
- Some patients suffering from severe conditions may not develop immunity to coronavirusHigh levels of a molecule in Covid patients may prevent them from developing immunity.20 Aug, 2020, 06.01 PM IST
- Kiran Mazumdar-Shaw on vaccines, India's tally and where Karnataka lost the Covid plot"Everybody is waiting for a Covid-19 vaccine to come out as soon as possible. However, before such a vaccine can go from 'lab to market', i...26 Jul, 2020, 09.32 PM IST
- We are going to do phase-4 trial of psoriasis drug on Covid patients: Kiran Mazumdar ShawThe Drug Controller gave Biocon an restricted emergency use authorisation to try out and continue to treat Covid-19 patients and then do a ...17 Jul, 2020, 03.57 PM IST
- 86% of active coronavirus cases confined to 10 states; Maha, TN account for 50%: GovtDespite being the second-most populous country of the world, the daily growth rate of new COVID-19 cases in India has been coming down cont...17 Jul, 2020, 12.32 PM IST
- Biocon defends limited trial patients for Itolizumab nod, says followed science of "highest order"The company is marketing the drug as a replacement to Roche Pharma’s Tocilizumab (originally approved for rheumatoid arthritis) that is cur...14 Jul, 2020, 12.05 PM IST
- Biocon to take on Roche Pharma with its psoriasis drug to treat moderate to severe Covid patientsThe company is marketing the drug as a replacement to Roche’s tocilizumab (originally approved for rheumatoid arthritis) that is currently ...14 Jul, 2020, 12.03 PM IST
- Biocon gets DCGI nod to use Itolizumab in moderate to severe Covid-19 patientsBiocon said the approval is based on the results from the successful conclusion of a randomized, controlled clinical trial at multiple hosp...11 Jul, 2020, 05.12 PM IST
- Sanofi halts trials of IL-6 drug for Covid-19, India to continue with trial of another drug of similar classThe decision casts a shadow on other similar classes of drugs such as Tocilizumab by Swiss drug maker Roche pharma, that are under trial fo...07 Jul, 2020, 10.25 PM IST
- Scientists discover small proteins which may reduce inflammation caused by COVID-19The therapeutic, described in the journal Cell Reports, is called TAT CARMIL1, and is actually a combination of two naturally occurring sma...05 Jul, 2020, 02.40 PM IST
- Biosimilar drugs can help us reach $1 billion target soon: Christiane Hamacher, CEO, Biocon BiologicsIt is all about reaching our $1billion revenue target by FY22 and to reach 5 million patients by end of 2022, says Christiane Hamacher.16 Jun, 2020, 11.03 AM IST
- Biocon gets DCGI nod for device to treat critical COVID-19 patientsThe company has been granted licence for emergency use of CytoSorb, an extracorporeal blood purification device CytoSorb to reduce pro-infl...27 May, 2020, 12.57 PM IST
- How COVID-19 can damage your heartSimply put, when a person is infected by the novel coronavirus his or her immune system tries to fight back. Too many cytokines — small pro...17 May, 2020, 10.18 AM IST
- Biocon says use of Itolizumab in COVID-19 treatment encouragingBiocon has witnessed encouraging results in the use of its novel biologic Itolizumab for treating some Covid-19 related conditions, the pha...16 May, 2020, 09.11 AM IST
- Treating Covid-19: Clinical trials using arthritis drug get nod“The CDSCO (Central Drugs Standard Control Organisation) has approved a vital randomised controlled trial on Covid-19 treatment with a biol...12 May, 2020, 12.28 PM IST
- Are the young more prone to Swine Flu?Close to three months and more than 900 cases later, doctors are no less wise about how H1N1 kills or why it kills.11 Aug, 2009, 11.51 AM IST
Load More
